//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
8,660.2518.8
Stock Analysis, IPO, Mutual Funds, Bonds & More

Aurobindo Pharma Ltd.

ET 500

Rank 2019
87
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    16:03 | 27-03-2020
  • BSE
    12:00 | 27-03-2020
392.25

Today's Change

30.85 (8.54%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

6,782,942

Open

388.00

Prev. Close

361.40

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)1.00
  • EPS-TTM (Rs.)43.80
  • BV/share (₹)237.11
  • 52Wk L/H294.70/ 838.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News

Aurobindo Pharma Ltd Stock Price F & O Quotes

Buy Aurobindo Pharma, price target Rs 495: CK Narayan| Recos
Buy
Sell Aurobindo Pharma, price target Rs 410: Arun Kumar| Recos
Sell
Buy Aurobindo Pharma, target price Rs 494: Jay Thakkar| Recos
Buy
Buy Aurobindo Pharma, target Rs 640: Kunal Bothra| Recos
Buy
Buy Aurobindo Pharma, target Rs 625: CK Narayan| Recos
Buy
Sell Aurobindo Pharma, target Rs 560: Shrikant Chouhan| Recos
Sell
Buy Aurobindo Pharma, target Rs 618: Jay Thakkar| Recos
Buy
Buy Aurobindo Pharma, target Rs 618: Dr CK Narayan| Recos
Buy
Trending stocks: Aurobindo Pharma shares jump 9%| News
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Update On US FDA Inspection At Our Unit VIII - Reg.,| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Earnings Call Transcript| Announcement
Aurobindo Pharma Ltd.Further update on US FDA Inspection at our Unit IV| Announcement
Aurobindo Pharma Ltd.Update On US FDA Inspection At Our Unit IV - Reg.,| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Updates on Acquisition| Announcement

Aurobindo Pharma Ltd. Share Price Updates

Aurobindo Pharma Ltd. share price up by 8.54% from its previous close of Rs 361.40. Aurobindo Pharma Ltd. stock last traded price is 392.25
Aurobindo Pharma Ltd. Share Price
Value
Today/Current/Last
392.25
Previous Day
361.40
What's your view on Aurobindo Pharma for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.
Quarterly Results

Figures in Rs. Cr
Dec 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
5,799.44
5.10
12.06
0.00
8154.85
Other Operating Income
95.56
16.25
1.22
0.00
136.45
Operating Profit
1,208.04
5.95
11.20
-27.67
2683.77
Other Income
30.93
50.00
-51.56
-0.05
119.88
EBITDA
1,238.97
6.73
7.71
-27.67
2683.77
Interest
37.11
-9.36
-22.12
-0.10
111.00
Depreciation
250.13
2.80
53.34
0.00
546.99
Tax
232.86
3.78
13.71
-9.24
767.02
Net Profit
705.45
10.25
-0.95
-835.00
1019.38
EPS (₹)
12.04
10.26
-0.91
-94.30
31.95

Aurobindo Pharma Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
392.25
8.54
13.14
-24.49
-15.30
-49.39
-41.46
-34.90
548.10
-1.89
-14.62
-17.31
-28.91
-24.26
-62.40
-71.96
407.65
5.57
3.78
-3.22
-15.27
-22.43
-31.15
-41.26
252.70
-1.62
-11.58
-3.35
-1.21
-23.42
-43.83
-23.65
2916.50
-1.09
0.66
-4.91
0.65
5.48
10.81
-14.61
2344.95
1.64
-0.16
-11.23
16.25
33.97
6.04
0.00
1860.15
2.47
-1.78
-14.24
-0.20
-1.43
32.63
63.42
1245.05
-3.47
-9.47
-7.63
8.99
34.51
114.90
93.14
1862.55
-1.10
-6.63
-13.63
1.77
11.80
193.52
107.61
277.70
-1.70
1.17
-7.09
-5.03
-7.79
47.13
292.01
765.90
3.69
-0.27
-22.65
-8.29
-3.69
98.39
370.60
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Aurobindo Pharma Ltd Risk Return Comparison

with peersNew

Aurobindo Pharma Ltd
Financial Comparison

with peers
Management Efficiency
Aurobindo Pharma Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
17.02
8.97
-99.01
47.57
Return on Assets (%)
9.06
5.58
-27.48
26.25
Return on capital Employed (%)
10.35
5.73
-130.86
23.02
Fixed Assets Turnover (x)
1.06
-1.83
-193.68
2.83
Profitability and Growth
Gross Profit Margin (%)
16.78
-8.24
-980.00
34.42
Operating Profit Margin(%)
20.20
0.75
-896.19
37.94
Net Profit margin (%)
12.08
1.93
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.47
1.62
0.08
9.50
Current Ratio (x)
2.75
2.36
0.21
9.50
Cash ratio (x)
0.34
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.01
0.29
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
2.17
3.92
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Aurobindo Pharma Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters285,925,93448.80
ForeignInstitutions125,535,96121.42
Others24,469,2484.18
NBanksMutualFunds74,862,24212.78
GeneralPublic54,811,0319.35
FinancialInstitutions2,334,1930.40
ForeignPromoter18,000,0003.07

MF Ownership Of Aurobindo Pharma Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
HDFC Balanced Advantage Direct-G
Portfolio as on 29-02-2020
Hybrid: Dynamic Asset Allocation
13797328
32.63%
1.7%
697.45
HDFC Equity Direct-G
Portfolio as on 29-02-2020
Equity: Multi Cap
9880295
0.00%
2.33%
499.45
HDFC Hybrid Equity Direct-G
Portfolio as on 29-02-2020
Hybrid: Aggressive Hybrid
7361000
0.00%
1.97%
372.10
HDFC Mid-Cap Opportunities Direct-G
Portfolio as on 29-02-2020
Equity: Mid Cap
4627400
12.11%
1.03%
233.92
HDFC Top 100 Direct-G
Portfolio as on 29-02-2020
Equity: Large Cap
3832450
0.00%
1.15%
193.73

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 22986.37 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 5799.44 Crore, up 5.10 % from last quarter Sales of Rs 5518.27 Crore and up 12.06 % from last year same quarter Sales of Rs 5175.26 Crore Company has reported net profit after tax of Rs 705.95 Crore in latest quarter.

The company’s top management includes Dr.M Sivakumaran, Mr.P V Ramprasad Reddy, Mr.P Sarath Chandra Reddy, Mr.N Govindarajan, Mr.M Sitarama Murthy, Mr.M Madan Mohan Reddy, Mr.K Ragunathan, Mr.K Nithyananda Reddy, Dr.(Mrs.)Avnit Bimal Singh, Mrs.Savita Mahajan. Company has BSR & Associates LLP as its auditors As on 31-12-2019, the company has a total of 585,938,609 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors